Radioimmunotherapy for Small Cell Lung Cancer
Author Information
Author(s): S. Yonedal, M. Fujisawa, J. Watanabe, T. Okabe, F. Takaku, T. Homma, K. Yoshida
Primary Institution: Saitama Cancer Center, University of Tokyo
Hypothesis
Can 131I-labelled monoclonal antibody TFS-4 effectively treat small cell lung cancer in mice?
Conclusion
The study found that 131I-labelled TFS-4 significantly inhibited tumor growth in small cell lung cancer xenografts in nude mice.
Supporting Evidence
- 131I-labelled TFS-4 showed specific accumulation in tumor tissue.
- Complete disappearance of the tumor was observed in one mouse after treatment.
- Administration of 300-500 pCi of TFS-4 significantly inhibited tumor growth.
Takeaway
This study shows that a special medicine can help shrink lung cancer tumors in mice by using a targeted approach.
Methodology
The study used nude mice with transplanted small cell lung cancer and treated them with varying doses of 131I-labelled TFS-4, measuring tumor growth over time.
Limitations
The study was conducted on a small number of animals and may not fully represent human responses.
Participant Demographics
Female BALB/c nude mice, 4-6 weeks old.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website